TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 5 | 6 | 2 | -2 | 32 | -20 | 4 |
| P | %wins | 100 | 100 | 50 | 50 | 50 | 0 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/24/12 09:45 | 2/22/12 | CYTR | Cytrx Corp | DE | Health | BioPrd | Biological Products, (No Diag | Wennekamp Richard L. | CA | D | P.m | 36 | 0.3207 | 0 | 112 | 999% | 117 | D | -73 | -64 | -3 | -11 | 10 | 10 | -14 | 7 | 6 | 9 | 22 | 36 | 103 | -17 | |
2/7/05 17:04 | 8/30/04 | CYTR | Cytrx Corp | DE | Health | BioPrd | Biological Products, (No Diag | Wennekamp Richard J | CA | D | P | 5 | 1.07 | 0 | 5 | New | 5 | D | 440 | -8 | 47 | 32 | 24 | 33 | 13 | 1 | 3 | 3 | -19 | -39 | -39 | -22 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |